[Asia Economy Reporter Minwoo Lee] Saltlux announced on the 29th that it has invested 1 billion KRW in cash to establish the bio-venture company Zeromix. With this, Saltlux will secure a 50% stake in Zeromix.



Saltlux stated, "We have established a venture company for the development of anticancer drugs and drug repositioning business," adding, "The purpose is to create synergy for new business entry and to participate in management."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing